Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Qiagen (QGEN) Other Non Operating Income (2016 - 2025)

Qiagen's Other Non Operating Income history spans 17 years, with the latest figure at -$132000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 104.71% to -$132000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.6 million, a 799.86% decrease, with the full-year FY2025 number at -$6.6 million, down 799.86% from a year prior.
  • Other Non Operating Income hit -$132000.0 in Q4 2025 for Qiagen, up from -$1.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for QGEN hit a ceiling of $8.5 million in Q1 2023 and a floor of -$11.0 million in Q2 2023.
  • Historically, Other Non Operating Income has averaged -$55166.7 across 5 years, with a median of -$127500.0 in 2022.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 3726.81% in 2023 and later tumbled 3065.85% in 2025.
  • Tracing QGEN's Other Non Operating Income over 5 years: stood at $2.1 million in 2021, then crashed by 105.82% to -$123000.0 in 2022, then skyrocketed by 1271.54% to $1.4 million in 2023, then surged by 94.66% to $2.8 million in 2024, then tumbled by 104.71% to -$132000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for QGEN at -$132000.0 in Q4 2025, -$1.3 million in Q3 2025, and -$1.3 million in Q2 2025.